Antibiotics: Global Markets to 2023
- BCC Research
- November 2018
- 158 pages
The antibiotics market growth outlook is positive with significant growth potential for beta lactams and tetracyclines antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobialresistant drugs at affordable prices. At the same time, factors such as rising disposable incomes and increasing spending on healthcare in emerging markets, increasing grants from government agencies for antibiotic drugs research and development and rising incidence of infectious diseases are contributing to the growth of the market.
The antibiotics market reached a value of nearly REDACTED in 2018 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED to nearly REDACTED by 2023. Antibiotic drugs are commonly used for treatment of acne, bronchitis, conjunctivitis (pink eye), otitis media (ear infection), sexually transmitted diseases (STDs), skin or soft tissue infection, streptococcal pharyngitis (strep throat), travelers diarrhea, upper respiratory tract infection and urinary tract infections.
The market for antibiotics is fragmented. Major players in the market are Merck & Company, Inc., Pfizer Inc., Sanofi S.A., Novartis AG, Bayer AG and others.
The Beta lactams were the largest segment in the antibiotics market in 2018 at REDACTED. The highest growth is projected to come from the tetracyclines segment, which is forecast to grow at a CAGR of REDACTED. Major factors for this growth include increasing use of these drugs to treat acne and other skininfections and respiratory tract infections such as pneumonia, and genital and urinary infections. North America is the largest regional market for antibiotics, accounting for REDACTED of the global total. It was followed by Western Europe and Asia-Pacific. Going forward, the fastest growth in the antibiotics market is expected in Asia-Pacific, where it is expected to grow at a CAGR of REDACTED,
followed by Africa where growth at a CAGR of REDACTED is forecast.
The USA is the largest country in terms of value in the antibiotics market. China and India are forecast to have the fastest growth, growing at a CAGR of REDACTED and REDACTED, respectively.
The antibiotics market is challenged by restraints such as low return on investment, pricing pressure from regulators, antimicrobial resistance, drug patents expiry and antibiotics drug shortages."
This research report categorizes the antibiotics market by type. The product types are betalactams, fluoroquinolones, macrolides, tetracycline and other antibiotic classes.
- 79 data tables
- Comprehensive overview of the global markets for antibiotics
- Analyses of the global market trends with data from 2014 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Regional dynamics of antibiotics for North America, Europe, Asia-Pacific and Other emerging markets
- Country specific data and analysis for United States, Canada, Mexico, Japan, China, India, France, Germany, U.K., Italy, Spain and Middle East and Africa
- Evaluation of the current trends and market dynamics, especially growth drivers and inhibitors, as well as cohesive government policies and regulatory updates
- A relevant patent analysis within the antibiotics industry
- Key mergers and acquisitions in the market
- Company profiles of the major market players in the industry, including Bayer AG, Merck & Company, Inc., Novartis AG, Pfizer Inc., and Sanofi S.A."
Have query on this report?Make an Enquiry
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Summary Table : Global Antibiotics Market, 2018-2023
Table 1 : Global Antibiotics Historic Market, Through 2018
Table 2 : Global Antibiotics Market, Through 2023
Table 3 : Global Antibiotics Market, by Segment, 2018
Table 4 : Global Antibiotics Market, Historic and Forecast Growth Rate, by Segment, 2014-2023
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Antibiotics
AntibioticsChinese Markets for Antibiotics
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017